An Expert’s Guide to SABCS 2024: A Preview of the Top Abstracts

Content Format:

Conference Coverage

Date:

Dec 06, 2024

Credit Type:

--

Credits:

--
Conversaciones sobre el cáncer de mama RH positivo/HER2 negativo en el panorama terapéutico en expansión de los inhibidores de CDK4/6

Content Format:

PDF

Date:

Aug 21, 2024

Credit Type:

--

Credits:

--
Conversas sobre o câncer: o cenário terapêutico em expansão para inibidores de CDK4/6 em câncer de mama HR-positivo/HER2-negativo

Content Format:

PDF

Date:

Aug 19, 2024

Credit Type:

--

Credits:

--
Especialistas respondem às suas perguntas sobre inibidores de CDK4/6 no câncer de mama HR+/HER2-

Content Format:

PDF

Date:

Aug 19, 2024

Credit Type:

--

Credits:

--
Des experts répondent à vos questions concernant les inhibiteurs de CDK4/6 dans le cancer du sein HR+/HER2-

Content Format:

PDF

Date:

Aug 09, 2024

Credit Type:

--

Credits:

--
Conversations autour du cancer portant sur l'élargissement du paysage thérapeutique des inhibiteurs de CDK4/6 dans le traitement du cancer du sein HR+/HER2-

Content Format:

PDF

Date:

Jul 26, 2024

Credit Type:

--

Credits:

--
InterACT Oncology Team Training: Improving Clinical Outcomes for Patients With High-Risk HR-Positive/HER2-Negative Early-Stage Breast Cancer

Content Format:

Slideset

Date:

Jul 25, 2024

Credit Type:

--

Credits:

--
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer

Content Format:

Podcast Episodes

Date:

Jul 09, 2024

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Experts Answer Your Questions on CDK4/6 Inhibitors in HR+/HER2- Breast Cancer

Content Format:

Clinical Thought

Date:

Jul 05, 2024

Credit Type:

ABIM MOC | AMA

Credits:

0.25
Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer

Content Format:

Video

Date:

Jun 17, 2024

Credit Type:

ABIM MOC | AMA

Credits:

1.50
Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer

Content Format:

Slideset

Date:

May 30, 2024

Credit Type:

ABIM MOC | AMA

Credits:

1.00
Improving Outcomes in Patients With High-Risk Breast Cancer: Expert Guidance and Team Training for HR-Positive/HER2-Negative Disease

Content Format:

Text Module

Date:

Mar 22, 2024

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

Content Format:

Video

Date:

Mar 07, 2024

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Highlights From the 2023 San Antonio Breast Cancer Symposium

Content Format:

Text Module

Date:

Feb 23, 2024

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.25
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

Content Format:

Slideset

Date:

Jan 23, 2024

Credit Type:

--

Credits:

--
How I Manage Key Toxicities With Adjuvant CDK4/6 Inhibitors for Early Breast Cancer

Content Format:

Clinical Thought

Date:

Dec 22, 2023

Credit Type:

--

Credits:

--
HR-Positive/HER2-Negative Breast Cancer: Patient–Provider Communication Checklist

Content Format:

PDF

Date:

Dec 22, 2023

Credit Type:

--

Credits:

--
Educational Opportunities to Improve Community Healthcare Professionals’ Management of High-Risk HR-Positive/HER2-Negative Early Breast Cancer

Content Format:

PDF

Date:

Dec 06, 2023

Credit Type:

--

Credits:

--
An Expert’s Guide to SABCS 2023: A Preview of the Top Abstracts

Content Format:

Conference Coverage

Date:

Dec 04, 2023

Credit Type:

--

Credits:

--
An Expert’s Guide to ESMO 2023: A Preview of the Top Abstracts

Content Format:

Conference Coverage

Date:

Oct 19, 2023

Credit Type:

--

Credits:

--
Metastatic Breast Cancer: Patient-Provider Communication Checklist

Content Format:

PDF

Date:

Oct 19, 2023

Credit Type:

--

Credits:

--
Applying the Latest Developments in Metastatic Breast Cancer Through Education of Healthcare Professionals, Patients, and Caregivers

Content Format:

Slideset

Date:

Oct 11, 2023

Credit Type:

--

Credits:

--
Targeting AKT in Breast Cancer: Emerging Therapies

Content Format:

Video

Date:

Sep 22, 2023

Credit Type:

--

Credits:

--
Metastatic Breast Cancer: Patient-Provider Communication Checklist

Content Format:

PDF

Date:

Aug 29, 2023

Credit Type:

--

Credits:

--
Key Decision Points in Neoadjuvant and Adjuvant Treatment Selection for Early-Stage HER2-Negative Breast Cancer

Content Format:

PDF

Date:

Aug 28, 2023

Credit Type:

--

Credits:

--
My Thoughts on the Potential of AKT Inhibitors in Metastatic Breast Cancer

Content Format:

Clinical Thought

Date:

Aug 15, 2023

Credit Type:

--

Credits:

--
Targeting AKT in HER2-Negative Breast Cancer: Implications for Future Clinical Practice

Content Format:

Slideset

Date:

Jul 27, 2023

Credit Type:

--

Credits:

--
The Evolving Treatment of Early Breast Cancer: Expert Answers to FAQs

Content Format:

Clinical Thought

Date:

Jul 25, 2023

Credit Type:

--

Credits:

--
The New Treatment Paradigm and Ongoing Questions for Early-Stage TNBC

Content Format:

Slideset

Date:

Jun 02, 2023

Credit Type:

--

Credits:

--